Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma, and severe lower respiratory tract disease in infants and young children. The airway epithelium, which has a well-developed barrier regulated by tight junctions, is the first line of defense during respiratory virus infection. In upper airway human nasal epithelial cells (HNECs), however, the primary site of RSV infection, the mechanisms of replication and budding of RSV, and the epithelial cell responses, including the tight junctional barrier, remain unknown. To investigate the detailed mechanisms of replication and budding of RSV in HNECs and the epithelial cell responses, we established an RSV-infected model using human telomerase reverse transcriptase--transfected HNECs. We first found that the expression and barrier function of tight junction molecules claudin-4 and occludin were markedly induced together with production of proinflammatory cytokines interleukin 8 and tumor necrosis factor-α in HNECs after RSV infection, and the induction of tight junction molecules possibly contributed to budding of RSV. Furthermore, the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a protein kinase C δ/hypoxia-inducible factor-1α/nuclear factor-κB pathway. The control of this pathway in HNECs may be useful not only for prevention of replication and budding of RSV, but also in therapy for RSV-induced respiratory pathogenesis.
Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma, and severe lower respiratory tract disease in infants and young children. The airway epithelium, which has a well-developed barrier regulated by tight junctions, is the first line of defense during respiratory virus infection. In upper airway human nasal epithelial cells (HNECs), however, the primary site of RSV infection, the mechanisms of replication and budding of RSV, and the epithelial cell responses, including the tight junctional barrier, remain unknown. To investigate the detailed mechanisms of replication and budding of RSV in HNECs and the epithelial cell responses, we established an RSV-infected model using humantelomerase reverse transcriptase--transfected HNECs. We first found that the expression and barrier function of tight junction molecules claudin-4 and occludin were markedly induced together with production of proinflammatory cytokines interleukin 8 and tumor necrosis factor-α in HNECs after RSV infection, and the induction of tight junction molecules possibly contributed to budding of RSV. Furthermore, the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a protein kinase C δ/hypoxia-inducible factor-1α/nuclear factor-κB pathway. The control of this pathway in HNECs may be useful not only for prevention of replication and budding of RSV, but also in therapy for RSV-induced respiratory pathogenesis.
Respiratory syncytial virus (RSV) is a negative-stranded RNA virus in the genus Pneumovirus, family Paramyxoviridae and is the major cause of bronchitis, asthma, and severe lower respiratory tract disease in infants and young children (Bitko and Barik, 1998). The envelope of RSV contains three transmembrane surface proteins, the fusion glycoprotein (F protein), G glycoprotein (G protein), and SH protein. F protein is responsible for fusion of the viral envelope with the plasma membrane of the host target cell, and G protein mediates attachment of the virus particle to the target cell (Levine ; Collins ). Furthermore, during virus assembly in RSV-infected cells, virus filaments at the cell surface and inclusion bodies in the cytoplasm, which are caused by close physical interaction between the filamentous actin (F-actin) and the virus, were observed by ultrastructural analysis (Jeffree ).RSV infection is limited to the most superficial layer of polarized, ciliated cells in the respiratory tract epithelium, entering through the apical surface (Zhang ; Wright ). Late steps of the RSV life cycle include assembly and budding of the virus, which also occur at the apical membrane in polarized cells (Roberts ). RSV replicates in the airway mucosa, where it may produce uncomplicated upper respiratory infection or spread distally to the lower airways, producing more severe lower respiratory tract infection. The mechanisms of entry, replication, and budding of RSV, however, are still unclear in the upper airway, including in the nasal mucosa.Many signaling molecules are considered major players in RSV-induced respiratory pathogenesis (Tregoning ). RSV activates multiple signaling pathways, including those involving protein kinase C (PKC), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB) (Bitko ; Bitko and Barik, 1998; Chen ; Gower ). Activation of PKC plays a role in the early stages of RSV infection (Monick ). RSV causes hypoxia-inducible factor-1α (HIF-1α) stabilization, which is important in inflammation and edema formation (Kilani ). Furthermore, proinflammatory cytokines and chemokines induced by RSV are regulated via an NF-κB pathway (Yoboua ). Therefore, we hypothesized that the PKCδ/HIF-1α/NF-κB pathway might play an important role in RSV-induced respiratory pathogenesis.The airway epithelium is the first line of defense during respiratory virus infection (Holt ). The epithelial barrier is regulated in large part by the apicalmost intercellular junctions, referred to as tight junctions (Schneeberger ). Furthermore, tight junctions also separate the apical from the basolateral cell surface domains to establish epithelial cell polarity (Tsukita and Furuse, 1998). Tight junctions are formed by not only the integral membrane proteins claudins, occludin, tricellulin, JAMs (junctional adhesion molecules), and CAR (coxsackie and adenovirus receptor), but also many peripheral membrane proteins, including scaffold PDZ-expression proteins and cell polarity molecules (Tsukita ; Sawada ; Schneeberger and Lynch, 2004; Ikenouchi ). Moreover, it is also known that tight junctions include targets or receptors of viruses and bacteria such as claudin-1 and occludin as coreceptors of hepatitis C virus (HCV), JAM as a reovirus receptor, CAR, and some claudins as Clostridium perfringens enterotoxin receptors (Guttman and Finlay, 2009).We previously reported that, in human nasal epithelial cells (HNECs) in vivo and in vitro, occludin, JAM-A, ZO-1, ZO-2, claudin-1, -4, -7, -8, -12, -13, -14, and tricellulin were detected together with well-developed tight junction strands (Takano ; Kurose ; Ohkuni ). Furthermore, the humantelomerase reverse transcriptase (hTERT)-transfected HNECs with an extended life span that we previously established can be used as an indispensable and stable model for studying the regulation of tight junction proteins in human nasal epithelium (Kuruse ; Ohkuni ; Kamekura ; Ogasawara ). In TERT-transfected HNECs, treatment with transforming growth factor-β1 (TGF-β1) markedly induces claudin-4 expression (Kurose ). It is possible that tight junctions in HNECs may be useful new molecular targets for defense against respiratory virus infection.In this study, to investigate the detailed mechanisms of replication and budding of RSV in HNECs and the epithelial cell responses, including production of proinflammatory cytokines and induction of tight junctions, we established an RSV-infected model in HNECs using hTERT-transfected cells, and examined the expression of RSV/G and F proteins and virus filaments. We first found that the expression and function of tight junction molecules were markedly induced together with production of proinflammatory cytokines in HNECs after RSV infection, and the induction of tight junction molecules contributed to budding of RSV. Furthermore, the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a PKCδ/HIF-1α/NF-κB pathway. Our data provide new insights into the signaling mechanisms that contribute to RSV-induced respiratory pathogenesis.
RESULTS
RSV infects HNECs in vitro
We quantified the susceptibility of HNECs in vitro to RSV infection by using hTERT-transfected HNECs. When the HNECs were infected with RSV at multiplicity of infection (MOI) 1, the mRNA and protein of RSV/G protein were markedly increased from 24 h (Figure 1, A and B). At 24 h after infection by RSV, the expression of RSV/G and F proteins was detected in most cells by immunocytochemistry using specific antibodies (Figure 1C). In an enzyme-linked immunosorbent assay (ELISA) of the medium, the levels of interleukin 8 (IL-8) and tumor necrosis factor-α (TNF-α) were significantly increased in the live virus group compared with the noninfected controls and the group with UV-inactivated RSV (Figure 1D).
FIGURE 1:
RSV-infected HNECs. RT–PCR (A) and Western blot (B) for RSV/G protein in HNECs infected with RSV at an MOI of 1. (C) Phase contrast and immunostaining for RSV/G and F proteins in HNECs at 24 h after infection with RSV at an MOI of 1. Black bar: 40 μM; white bar: 20 μM. (D) ELISA for IL-8 and TNF-α from HNECs infected with RSV at an MOI of 1 or with UV-treated RSV. UV: RSV was inactivated by exposing the virus to UV light at 1 J. Data are means ± SEM, *p < 0.01 compared with 0 h. (E) SEM image and TEM image of HNECs at 24 h after infection with RSV at an MOI of 1. SEM bars: 400 nm; TEM bars: 1 μm. Inset image: 100 nm. Western blot (F) and immunostaining (G) for RSV/G protein in HNECs infected with RSV at an MOI of 1 from apical or basolateral regions by using double-chamber dishes. Bars: 40 μM.
RSV-infected HNECs. RT–PCR (A) and Western blot (B) for RSV/G protein in HNECs infected with RSV at an MOI of 1. (C) Phase contrast and immunostaining for RSV/G and F proteins in HNECs at 24 h after infection with RSV at an MOI of 1. Black bar: 40 μM; white bar: 20 μM. (D) ELISA for IL-8 and TNF-α from HNECs infected with RSV at an MOI of 1 or with UV-treated RSV. UV: RSV was inactivated by exposing the virus to UV light at 1 J. Data are means ± SEM, *p < 0.01 compared with 0 h. (E) SEM image and TEM image of HNECs at 24 h after infection with RSV at an MOI of 1. SEM bars: 400 nm; TEM bars: 1 μm. Inset image: 100 nm. Western blot (F) and immunostaining (G) for RSV/G protein in HNECs infected with RSV at an MOI of 1 from apical or basolateral regions by using double-chamber dishes. Bars: 40 μM.During RSV infection, it is thought that there is a close physical interaction between the filamentous actin and the virus, which is indicated by both the virus filaments and inclusion bodies (Jeffree ). In the RSV-infected HNECs, many virus filaments were observed on the cell surface by scanning electron microscopy (SEM), and inclusion bodies were also detected at submembranes by transmission electron microscopy (TEM), but they were not detected in the control (Figure 1E).To determine whether RSV infected from the apical or basolateral surfaces of HNECs, the cells were infected with RSV from apical or basolateral regions by using double chamber dishes. In Western blots, the RSV/G protein was detected only from the apical region (Figure 1F) and in immunocytochemistry, the expression of RSV/G from the apical group was greater than that from the basolateral group (Figure 1G). Thus HNECs were more susceptible to RSV infection from the apical surface than from the basolateral surface.
Gene expression changes in HNECs infected with RSV
We performed GeneChip analysis of HNECs infected with RSV, and selected gene probes that were up-regulated more than twofold compared with the controls (Table 1). In HNECs infected with RSV, up-regulation of IL-8 and TNF-α was confirmed together with a marked increase of the pattern recognition receptors RIG-I and MDA5. More interestingly, up-regulation of tight junction molecules claudin-2, -4, -7, -9, -14, and -19, occludin, ZO-2, cingulin, and MAGI-1 was observed in HNECs infected with RSV.
TABLE 1:
Gene probes that are up-regulated more than twofold to the control in RSV-infected hTERT-HNECs.
Gene name
ID
Gene Bank ID
Fold change (>2.0)
CLDN2
H200002539
NM_020384
2.9
CLDN4
H300004950
NM_001305
7.3
CLDN7
H200017305
NM_001307
2.3
CLDN9
H200009827
NM_020982
3.0
CLDN14
H200016568
NM_144492; NM_012130
2.8
CLDN19
H200009873
NM_148960
2.6
OCLN
opHsV0400004868
NM_002538
2.3
TJP2 (ZO-2)
H300020004
NM_002538
4.2
CGN (Cingulin)
H300009163
3.4
BAIAP1 (MAGI-1)
H300019020
NM_004742
2.2
TGFB1
opHsV0400000071
NM_002538
2.9
PRKCD (PKCδ)
H200014060
NM_212539; NM_006254
2.2
HIF-1α
H300017074
NM_181054; NM_001530
17.2
VEGFC
H200006638
NM_005429
6.3
NT5E
H200013920
NM_002526
6.9
NFKBIA
H200006833
NM_020529; NM_020529
4.1
NFKBIE
H200010505
NM_004556
6.7
NFKBIZ
H300020290
NM_031419; NM_001005474
3.9
IL8
opHsV0400000818
NM_000584
3.2
TNFA
H200015775
NM_000594
6.0
DDX58 (RIG1)
H200013521
NM_014314
37.1
IFIH1 (MDA5)
H200009565
NM_022168
25.9
Gene probes that are up-regulated more than twofold to the control in RSV-infectedhTERT-HNECs.
RSV infection induces tight junction protein claudin-4 in HNECs via a PKCδ/NF-κB signaling pathway
To confirm the up-regulation of tight junction proteins in HNECs infected with RSV, Western blotting, reverse transcription–PCR (RT–PCR), real-time PCR, and immunocytochemistry were performed. In Western blotting, the proteins of claudin-4 and occludin were increased gradually in a time-dependent manner after RSV infection (Figure 2A). In RT–PCR and real-time PCR, the mRNAs of claudin-4 and occludin were increased from 24 h after RSV infection, whereas no changes were observed in the non-infected control and the group with UV-inactivated RSV (Figure 2, B and C; Supplemental Figure 1). In immunocytochemistry at 24 h after RSV infection, claudin-4 and occludin were increased at the membranes of HNECs, compared with the control (Figure 3).
FIGURE 2:
Induction of claudin-4 and occludin in HNECs infected with RSV. (A) Western blot for claudin-4 and occludin in HNECs infected with RSV at an MOI of 1 or with UV-treated RSV. The corresponding expression levels of (A) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with 0 h. RT–PCR (B) and real-time PCR (C) for claudin-4 and occludin in HNECs infected with RSV at an MOI of 1. Data are means ± SEM, *p < 0.01 compared with 0 h. (D) Western blot for claudin-4 in HNECs pretreated with inhibitors of signaling pathways 30 min before infection with RSV at an MOI of 1 for 24 h. The corresponding expression levels of (D) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. PD: MAPK inhibitor PD98059; SB: p38 MAPK inhibitor SB203580; LY: PI3K inhibitor LY294002; GF: pan-PKC inhibitor GF109203X; SP: JNK inhibitor SP600125; IMD: NF-κB inhibitor IMD-0354. (E) Western blot for claudin-4 in HNECs pretreated with inhibitors of PKC isoforms 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCα: PKCα inhibitor Gö6976; iPKCδ: PKCδ inhibitor rottlerin; i PKCθ: PKCθ inhibitor myristoylated PKCθ pseudosubstrate peptide inhibitor; iPKCε: PKCε inhibitor PKCε translocation inhibitor. The corresponding expression levels of (E) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV.
FIGURE 3:
Images of inverted microscope and confocal laser scanning microscope using immunostaining for claudin-4 and occludin in HNECs 24 h after infection with RSV at an MOI of 1.
Induction of claudin-4 and occludin in HNECs infected with RSV. (A) Western blot for claudin-4 and occludin in HNECs infected with RSV at an MOI of 1 or with UV-treated RSV. The corresponding expression levels of (A) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with 0 h. RT–PCR (B) and real-time PCR (C) for claudin-4 and occludin in HNECs infected with RSV at an MOI of 1. Data are means ± SEM, *p < 0.01 compared with 0 h. (D) Western blot for claudin-4 in HNECs pretreated with inhibitors of signaling pathways 30 min before infection with RSV at an MOI of 1 for 24 h. The corresponding expression levels of (D) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. PD: MAPK inhibitor PD98059; SB: p38 MAPK inhibitor SB203580; LY: PI3K inhibitor LY294002; GF: pan-PKC inhibitor GF109203X; SP: JNK inhibitor SP600125; IMD: NF-κB inhibitor IMD-0354. (E) Western blot for claudin-4 in HNECs pretreated with inhibitors of PKC isoforms 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCα: PKCα inhibitor Gö6976; iPKCδ: PKCδ inhibitor rottlerin; i PKCθ: PKCθ inhibitor myristoylated PKCθ pseudosubstrate peptide inhibitor; iPKCε: PKCε inhibitor PKCε translocation inhibitor. The corresponding expression levels of (E) are shown as bar graphs. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV.Images of inverted microscope and confocal laser scanning microscope using immunostaining for claudin-4 and occludin in HNECs 24 h after infection with RSV at an MOI of 1.In the control HNECs in vitro, claudin-1 and -7, ZO-1, JAM-A, and E-cadherin were also detected by Western blotting and immunocytochemistry (Kurose ). In Western blotting, only claudin-1 was decreased at 72 h after RSV infection, whereas no change of claudin-7, ZO-1, JAM-A, or E-cadherin (Supplemental Figure 2) was observed. In immunocytochemistry at 24 h after RSV infection, ZO-1, JAM-A, and E-cadherin were increased at the membranes compared with the control (Supplemental Figure 3).To investigate which signaling pathways were associated with induction of claudin-4 by RSV infection, HNECs were pretreated with MAPK inhibitor PD98059, p38 MAPK inhibitor SB203580, phosphoinositide 3-kinase (PI3K) inhibitor LY294002, pan-PKC inhibitor GF109203X, c-Jun N-terminal kinase (JNK) inhibitor SP600125, and NF-κB inhibitor IMD-0354 at 30 min before RSV infection. In Western blotting, the up-regulation of claudin-4 after RSV infection was inhibited by pan-PKC inhibitor GF109203X and NF-κB inhibitor IMD-0354 (Figure 2D).As the up-regulation of claudin-4 after RSV infection was inhibited by the pan-PKC inhibitor, we investigated the effects of PKC isoforms. When HNECs were pretreated with PKCα inhibitor Gö6976, PKCδ inhibitor rottlerin, PKCθ inhibitor myristoylated PKCθ pseudosubstrate peptide inhibitor, or PKCε inhibitor PKCε translocation inhibitor peptide 30 min before RSV infection, PKCδ inhibitor rottlerin prevented up-regulation of claudin-4 at the same level as pan-PKC inhibitor GF109203X (Figure 2E).
PKCδ inhibitor and NF-κB inhibitor prevent replication of RSV, formation of virus filaments, and production of proinflammatory cytokines in HNECs after RSV infection
We investigated whether the PKCδ inhibitor and NF-κB inhibitor that prevented up-regulation of claudin-4 in HNECs after RSV infection affected replication of RSV, formation of virus filaments, and expression of proinflammatory cytokines.In Western blotting and real-time PCR, the up-regulation of claudin-4 after RSV infection was inhibited by pan-PKC inhibitor GF109203X, PKCδ inhibitor rottlerin, and NF-κB inhibitor IMD-0354 (Figure 4, A and B). In Western blots, the expression of RSV/G protein, which indicated the replication of RSV, was inhibited by the PKCδ inhibitor and NF-κB inhibitor (Figure 4A). In the ELISA, the production of IL-8 and TNF-α from HNECs after RSV infection was also inhibited by the PKCδ inhibitor and the NF-κB inhibitor (Figure 4C). In immunocytochemistry, up-regulation of claudin-4 and expression of RSV/G protein after RSV infection were markedly inhibited by the pan-PKC inhibitor, PKCδ inhibitor, and NF-κB inhibitor (Figure 4, D and E). Furthermore, the formation of virus filaments after RSV infection was inhibited by the pan-PKC inhibitor, PKCδ inhibitor, and NF-κB inhibitor (Figure 4F). When we investigated the cytotoxicity of the inhibitors of pan-PKC, PKCδ, and NF-κB in HNEC cells after RSV infection, cytotoxicity was not observed at the concentration of all inhibitors (Supplemental Figure 4).
FIGURE 4:
Inhibitors of pan-PKC, PKCδ, and NF-κB prevent replication of RSV and the epithelial cell responses in HNECs infected with RSV. Western blot (A) for claudin-4 and RSV/G protein, real-time PCR (B) for claudin-4, ELISA (C) for IL-8 and TNF-α, immunostaining for claudin-4 (D) and RSV/G protein (E), and SEM images (F) of HNECs pretreated with inhibitors of pan-PKC, PKCδ, and NF-κB 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCδ: PKCδ inhibitor rottlerin; IMD: NF-κB inhibitor IMD-0354. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. Bars of D and E: 40 μm, Bars of F: 1 μm.
Inhibitors of pan-PKC, PKCδ, and NF-κB prevent replication of RSV and the epithelial cell responses in HNECs infected with RSV. Western blot (A) for claudin-4 and RSV/G protein, real-time PCR (B) for claudin-4, ELISA (C) for IL-8 and TNF-α, immunostaining for claudin-4 (D) and RSV/G protein (E), and SEM images (F) of HNECs pretreated with inhibitors of pan-PKC, PKCδ, and NF-κB 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCδ: PKCδ inhibitor rottlerin; IMD: NF-κB inhibitor IMD-0354. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. Bars of D and E: 40 μm, Bars of F: 1 μm.
RSV infection induces formation of tight junction strands and barrier function via up-regulation of claudin-4 in HNECs
To investigate whether RSV induced the formation of tight junction strands and barrier function of HNECs, freeze-fracture and transepithelial electrical resistance (TER) measurement were performed. In freeze-fracture replicas at 24 h after RSV infection, the mean number of tight junction strands was significantly increased compared with the control and well-developed networks formed by continuous lines of tight junction strands (Figure 5A). For the barrier function, TER values were significantly increased by RSV infection from apical regions of HNECs compared with the control and RSV infection from basolateral regions (Figure 5B).
FIGURE 5:
Structures and barrier function of tight junctions in HNECs infected with RSV. (A) Freeze-fracture replica of HNECs 24 h after infection with RSV at an MOI of 1. Bar: 200 nm. Morphometric analysis of tight junction strands of A is shown as a bar graph. *p < 0.01 compared with control. (B) Barrier function measured as TER in HNECs infected with RSV at an MOI of 1 from apical or basolateral regions by using double-chamber dishes or with UV-treated RSV. UV: RSV was inactivated by exposing the virus to UV light at 1 J. Data are means ± SEM, *p < 0.01 compared with 0 h. (C) Immunostaining for RSV/G and F proteins and ZO-1 in HNECs at 8 h and 24 h after infection with RSV at an MOI of 1. Bars: 10 μm. (D) SEM images and TEM image of HNECs pretreated with inhibitors of pan-PKC, PKCδ, and NF-κB at 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCδ: PKCδ inhibitor rottlerin; IMD: NF-κB inhibitor IMD-0354. Bars of SEM: 1 μm; Bar of TEM: 400 nm.
Structures and barrier function of tight junctions in HNECs infected with RSV. (A) Freeze-fracture replica of HNECs 24 h after infection with RSV at an MOI of 1. Bar: 200 nm. Morphometric analysis of tight junction strands of A is shown as a bar graph. *p < 0.01 compared with control. (B) Barrier function measured as TER in HNECs infected with RSV at an MOI of 1 from apical or basolateral regions by using double-chamber dishes or with UV-treated RSV. UV: RSV was inactivated by exposing the virus to UV light at 1 J. Data are means ± SEM, *p < 0.01 compared with 0 h. (C) Immunostaining for RSV/G and F proteins and ZO-1 in HNECs at 8 h and 24 h after infection with RSV at an MOI of 1. Bars: 10 μm. (D) SEM images and TEM image of HNECs pretreated with inhibitors of pan-PKC, PKCδ, and NF-κB at 30 min before infection with RSV at an MOI of 1 for 24 h. GF: pan-PKC inhibitor GF109203X; iPKCδ: PKCδ inhibitor rottlerin; IMD: NF-κB inhibitor IMD-0354. Bars of SEM: 1 μm; Bar of TEM: 400 nm.
PKCδ inhibitor and NF-κB inhibitor prevent budding of RSV from apical surface of HNECs
In immunocytochemistry at 24 h after RSV infection, RSV/G and /F proteins were detected at submembranes of the HNEC apical surface, whereas they were observed around the nuclei at 8 h after RSV infection (Figure 5C). When RSV/G and /F proteins were detected at submembranes of the HNEC apical surface at 24 h after RSV infection, tight junction protein ZO-1 was observed at cell borders (Figure 5C).In SEM at 24 h after RSV infection, many small membranous substances were observed at the surfaces of HNECs together with cilia, whereas they were not detected in the control (Figure 5D). It is thought that they indicate budding of RSV, because in TEM at 24 h after RSV infection, a complex of electric, high-density particles is observed in the small membranous substances at the surface and in submembranes of HNECs (Figure 5D). Furthermore, pan-PKC inhibitor GF109203X, PKCδ inhibitor rottlerin, and NF-κB inhibitor IMD-0354 prevented the budding of RSV (Figure 5D).
RSV infection induces expression of claudin-4 but not RSV replication via production of TGF-β1 from HNECs
RSV infection induces the expression of TGF-β in epithelial A594 and PHBE cells (Gibbs ). We previously reported that treatment with TGF-β could induce the expression of claudin-4 in HNECs (Kurose ). Furthermore, in the present study, when we performed GeneChip analysis of HNECs infected with RSV, up-regulation of TGF-β1 and TGF-β receptor II was observed together with an increase of claudin-4 (Table 2).
TABLE 2:
Antibodies.
Dilution
Antibody
Type
IC
WB
Source
Claudin-1
pAb
1:1000
Zymed Laboratories (San Francisco, CA)
Claudin-4
pAb
1:100
1:1000
Zymed Laboratories
Claudin-7
pAb
1:1000
Zymed Laboratories
Occludin
pAb
1:100
1:1000
Zymed Laboratories
JAM-A
pAb
1:100
1:1000
Zymed Laboratories
ZO-1
pAb
1:100
1:1000
Zymed Laboratories
E-cadherin
mAb (36/E-cadherin)
1:200
1:1000
BD Biosciences (San Jose, CA)
RSV/G and /F proteins
mAb
1:100
1:4000
Tsutsumi et al., 1989
HIF-1α
mAb
1:1000
Novus Biologicals (Littleton, CO)
Phospho-PKCδ
pAb
1:1000
Cell Signaling Technology (Danvers, MA)
PKCδ
mAb
1:1000
BD PharMingen (San Diego, CA)
Phospho-pan-PKC
pAb
1:1000
Cell Signaling Technology
Pan-PKC
pAb
1:1000
Santa Cruz Biotechnology (Santa Cruz, CA)
Phospho-NF-κB
pAb
1:1000
Cell Signaling Technology
NF-κB
pAb
1:1000
Cell Signaling Technology
Actin
pAb
1:1000
Sigma-Aldrich
pAb, rabbit polyclonal antibody; mAb, mouse mAb.
Antibodies.pAb, rabbit polyclonal antibody; mAb, mouse mAb.We investigated whether up-regulation of claudin-4 in HNECs after RSV infection was caused via TGF-β signaling. In RT–PCR and real-time PCR after RSV infection, mRNAs of RSV/G protein, TGF-β1, and claudin-4 were significantly increased from 3 h, 12 h, and 24 h, respectively (Figure 6, A–C). The up-regulation of mRNAs of TGF-β1 and claudn-4 in HNECs after RSV infection was maintained from 24 h until 72 h, whereas no changes were observed in the non-infected control and the group with UV-inactivated RSV (Figure 6, D–F; Supplemental Figure 1). In Western blotting and real-time PCR, up-regulation of claudin-4 after RSV infection was inhibited by TGF-β receptor I kinase inhibitor (iTGF-βR; Figure 6, G and H), but expression of RSV/G protein, which indicated replication of RSV, was not inhibited by the iTGF-βR (Figure 6, G and H). In immunocytochemistry, the iTGF-βR prevented up-regulation of claudin-4 at the membranes but not expression of RSV/G protein after RSV infection (Figure 6I).
FIGURE 6:
Induction of TGF-β1 in HNECs infected with RSV. RT–PCR (A and D) and real-time PCR (B, C, E, and F) for RSV/G protein, TGF-β1, and claudin-4 in HNECs infected with RSV at an MOI of 1. Data are means ± SEM, *p < 0.01, compared with 0 h. Western blot (G) and real-time PCR (H) for claudin-4, and immunostaining (I) for claudin-4 and RSV/G protein in HNECs pretreated with iTGF-βR 30 min before infection with RSV at an MOI of 1 for 24 h. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. Bars: 40 μm.
Induction of TGF-β1 in HNECs infected with RSV. RT–PCR (A and D) and real-time PCR (B, C, E, and F) for RSV/G protein, TGF-β1, and claudin-4 in HNECs infected with RSV at an MOI of 1. Data are means ± SEM, *p < 0.01, compared with 0 h. Western blot (G) and real-time PCR (H) for claudin-4, and immunostaining (I) for claudin-4 and RSV/G protein in HNECs pretreated with iTGF-βR 30 min before infection with RSV at an MOI of 1 for 24 h. Data are means ± SEM, *p < 0.01 compared with control, #p < 0.01 compared with RSV. Bars: 40 μm.
Possible regulation of claudin-4 in HNECs after RSV infection via a TGF-β1/PKCδ/HIF-1α/NF-κB signaling pathway
In GeneChip analysis of HNECs infected with RSV, up-regulation of PKCδ, HIF-1α, HIF-1α–associated genes VEGF and NT5, and NF-κB was observed (Table 1). Furthermore, in Western blotting, phospho-PKCδ, HIF-1α, and phospho-NF-κB were increased together with induction of claudin-4 after RSV infection (Figure 7A).
FIGURE 7:
Induction of claudin-4 in HNECs via a TGF-β/PKCδ/HIF-1α/NK-κB pathway. (A) Western blot for claudin-4, phospho-pan-PKC, phospho-PKCδ, HIF-1α, and phospho-NK-κB in HNECs infected with RSV at an MOI of 1. Western blot (B) for claudin-4, phospho-PKCδ, HIF-1α ,and phospho-NK-κB in HNECs at 24 h after treatment with 0.1–10 ng/ml TGF-β1. (C) Western blot for claudin-4 in HNECs pretreated with iTGF-βR 30 min before treatment with 10 ng/ml TGF-β1. Western blot (D) for claudin-4, phospho-PKCδ, and phospho-NK-κB in HNECs 24 h after treatment with hypoxia. The corresponding expression levels of (A–D) are shown as bar graphs. Data are means ± SEM. *p < 0.01 compared with control, #p < 0.01 compared with RSV.
Induction of claudin-4 in HNECs via a TGF-β/PKCδ/HIF-1α/NK-κB pathway. (A) Western blot for claudin-4, phospho-pan-PKC, phospho-PKCδ, HIF-1α, and phospho-NK-κB in HNECs infected with RSV at an MOI of 1. Western blot (B) for claudin-4, phospho-PKCδ, HIF-1α ,and phospho-NK-κB in HNECs at 24 h after treatment with 0.1–10 ng/ml TGF-β1. (C) Western blot for claudin-4 in HNECs pretreated with iTGF-βR 30 min before treatment with 10 ng/ml TGF-β1. Western blot (D) for claudin-4, phospho-PKCδ, and phospho-NK-κB in HNECs 24 h after treatment with hypoxia. The corresponding expression levels of (A–D) are shown as bar graphs. Data are means ± SEM. *p < 0.01 compared with control, #p < 0.01 compared with RSV.For the mechanisms of the up-regulation of claudin-4 in HNECs after RSV infection, we hypothesized the possible regulation of claudin-4 via a TGF-β1/PKCδ/HIF-1α/NF-κB signaling pathway and confirmed it by using treatment with TGF-β1 and under hypoxia (2% O2).When HNECs were treated with 0.1–10 ng/ml TGF-β1 for 24 h, up-regulation of claudin-4, phospho-PKCδ, HIF-1α, and phospho-NF-κB was increased from 0.1, 0.1, 0.1, and 1 ng/ml, respectively, in Western blotting (Figure 7B). In RT–PCR, HIF-1α mRNA was increased from 0.1 ng/ml TGF-β1 (Supplemental Figure 5). In Western blotting, up-regulation of claudin-4 after treatment with 10 ng/ml TGF-β was inhibited by iTGF-βR (Figure 7C).When HNECs were incubated in a 5% CO2/2% O2 incubator balanced by nitrogen for 24 h, claudin-4, phospho-PKCδ, HIF-1α, and phospho-NF-κB were increased from 1, 2, 2, and 1 h after treatment with hypoxia, respectively, in Western blotting (Figure 7D). In RT–PCR, HIF-1α mRNA was increased from 2 h (Supplemental Figure 5).
Possible regulation of claudin-4 in HNECs after RSV infection and replication of RSV via a HIF-1α signaling pathway
To investigate whether HIF-1α directly affected claudin-4 expression and replication of RSV after the infection, HNECs were pretreated with three siRNAs of HIF-1α before RSV infection. Two siRNAs of HIF-1α slightly prevented up-regulation of claudin-4 and expression of RSV/G protein at 24 h after RSV infection in Western blotting (Figure 8A).
FIGURE 8:
Overview of signal transduction events in HNECs infected with RSV.
Overview of signal transduction events in HNECs infected with RSV.
DISCUSSION
In the present study, we established an RSV-infected model in HNECs using hTERT-transfected cells and to our knowledge first demonstrated that the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a PKCδ/HIF-1α/NF-κB pathway.In the polarized cells of respiratory tract epithelium, RSV enters through the apical surface, and the assembly and budding of the virus occur at the apical membrane (Roberts ; Zhang ; Wright ). In hTERT-transfected HNECs after RSV infection, RSV/G and F proteins were detected in most cells together with production of proinflammatory cytokines IL-8 and TNF-α. Furthermore, RSV entered through the apical surface of the HNEC, and the assembly and budding of the virus, indicated as virus filaments and many small membranous substances, also occurred at the apical membrane or submembrane. These results suggested that hTERT-transfected HNECs might function as an RSV-infected model for HNECs to investigate the regulation of replication and budding of the virus and the epithelial cell responses.Some claudins are degraded during West Nile virus infection (Medigeshi ). In polarized airway epithelial cells infected with rhinoviruses, TER is decreased together with the loss of ZO-1 (Sajjan ). Infection with mouse adenovirus type 1 results in reduced expression and cell surface localization of tight junction proteins along with loss of barrier properties (Gralinski ). The effects of RSV infection on tight junctions of upper airway HNECs remain known, however.RSV infection alters the expression of adhesion molecules intercellular adhesion molecule 1 and E-cadherin in A549 cells (Wang ). When we performed GeneChip analysis of HNECs infected with RSV compared with the control, we found dramatic up-regulation of tight junction molecules claudin-2, -4, -7, -9, -14, and -19, occludin, ZO-2, cingulin, and MAGI-1, together with up-regulation of proinflammatory cytokines IL-8 and TNF-α, as well as viral double-strand-RNA–induced pattern recognition receptors RIG-I and MAD5. In HNECs infected with live RSV, but not UV-treated RSV, up-regulation of claudin-4 and occludin was confirmed at the levels of protein and mRNA together with up-regulation of the tight junctional barrier function, whereas claudin-1 was decreased at 72 h after RSV infection. In immunocytochemistry at 24 h after RSV infection, not only claudin-4 and occludin but also ZO-1, JAM-A, and E-cadherin were increased at the membranes together with localization of RSV/G and /F proteins at submembranes of the apical surface. These results suggested that the tight junction molecules induced after RSV infection, which also play a crucial role in epithelial cell polarity, might contribute to the budding of the virus from the HNEC apical surface.It is known that RSV activates multiple signaling pathways, including those involving PKC, MAPK, and NF-κB (Bitko ; Bitko and Barik, 1998; Chen ; Gower ). Activation of PKC plays a role in the early stages of RSV infection (Monick ). Previous studies have shown that PKC activation plays a role in the early stages of RSV infection (Sieczkarski ) and RSV activates PKCδ at early time points after infection by the virus (Monick ). RSV causes HIF-1α stabilization, which is important in inflammation and edema formation (Kilani ). Furthermore, proinflammatory cytokines and chemokines induced by RSV are regulated via an NF-κB pathway (Yoboua ). In the present study, in HNECs after RSV infection, up-regulation of phospho-PKCδ, HIF-1α, and phospho-NF-κB was observed by Western blotting. Upregulation of claudin-4 in HNECs after RSV infection was prevented by inhibitors of PKCδ and NF-κB. The inhibitors of PKCδ and NF-κB also prevented expression of RSV/G protein, the presence of virus filaments and small membranous substances at the apical membrane or submembrane, and production of proinflammatory cytokines after RSV infection. These results suggest that a PKCδ/HIF-1α/NF-κB pathway plays an important role in the replication and budding of RSV and the epithelial cell responses in HNECs.RSV infection induces the expression of TGF-β in epithelial A594 and PHBE cells and causes cell-cycle arrest of lung epithelial cells through a TGF-β autocrine pathway (Gibbs ). The TGF-β signaling pathway is mediated via PKCδ (Lee ). Furthermore, we previously reported that treatment with TGF-β1 could induce claudin-4 expression at the protein and mRNA levels in HNECs (Kurose ). We investigated whether TGF-β was closely associated with up-regulation of claudin-4 expression after RSV infection. In HNECs after RSV infection, an increase of TGF-β1 mRNA was observed by GeneChip analysis (Table 1). It was enhanced later than the presence of mRNA of RSV/G protein and earlier than the increase of claudin-4 mRNA, and was maintained, like claudin-4 mRNA, for a long time. iTGF-βR prevented up-regulation of claudin-4 protein but not the presence of RSV/G protein in HNECs after RSV infection. Treatment with TGF-β1 induced not only claudin-4 expression but also expression of HIF-1α, phospho-PKCδ, and phospho-NF-κB in HNECs. These findings indicated that up-regulation of claudin-4 after RSV infection was in part regulated by a TGF-β/PKCδ/HIF-1α/NF-κB pathway in a TGF-β autocrine manner.PKCδ regulates the stability of HIF-1α under hypoxia (Lee ). HIF-1α has been identified as a key regulator of the inflammatory transcription factor NF-κB (Walmsley ). In the present study, GeneChip analysis of HNECs after RSV infection showed that expression of PKCδ, HIF-1α, and the HIF-1α-associated genes VEGF and NT5 was increased (Table 1). To investigate whether HIF-1α directly regulated expression of claudin-4 and the replication of RSV in HNECs after the virus infection, HNECs were incubated under hypoxia or treated with siRNAs of HIF-1α. In HNECs cultured under hypoxia, up-regulation of HIF-1α, claudin-4, phospho-PKCδ, and phospho-NF-κB was observed. In HNECs after RSV infection, siRNAs of HIF-1α prevented up-regulation of claudin-4 and the presence of RSV/G protein. These results suggested that HIF-1α directly regulated the replication of RSV and the epithelial cell response in HNECs.Some tight junction molecules are also receptors of viruses. These receptors include JAM as a reovirus receptor, CAR, and claudin-1 and occludin as coreceptors of HCV (Cohen ; Campbell ; Evans ; Guttman and Finlay, 2009; Ploss ). We investigated the possibility that claudin-4 and occludin, which were induced after RSV infection, were receptors of RSV in HNECs. When HNECs were pretreated with siRNAs of claudin-4 or occludin, however, no changes of RSV/G protein, virus filaments, and many small membranous substances were observed in HNECs after RSV infection (Supplemental Figure 6, A and B). These findings indicate that claudin-4 and occludin are not receptors of RSV in HNECs and that there are other mechanisms of the budding of RSV.In conclusion, we established an RSV-infected model in normal HNECs using hTERT-transfected cells and found that the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a PKCδ/HIF-1α/NF-κB pathway. In addition, it was thought that the PKCδ/HIF-1α/NF-κB pathway via TGF-β in an autocrine manner might also be important in the epithelial cell responses at the late stage after RSV infection (Figure 8). Inhibition of replication and budding of RSV in upper airway HNECs via these mechanisms might contribute to useful new preventive treatments for severe lower respiratory tract disease in infants and young children.
MATERIALS AND METHODS
Reagents and inhibitors
Recombinant humanIL-8, TNF-α, and TGF-β1 were purchased from PeproTech EC (London, UK). A pan-PKC inhibitor (GF109203X), MAPK inhibitor (PD98059), p38 MAPK inhibitor (SB203580), PI3K inhibitor (LY294002), PKCα inhibitor (Gö6976), PKCδ inhibitor (rottlerin), PKCθ inhibitor (myristoylated PKCθ pseudosubstrate peptide inhibitor), PKCε inhibitor (PKCε translocation inhibitor peptide), and iTGF-βR were purchased from Calbiochem-Novabiochem (San Diego, CA). JNK inhibitor SP600125 and NF-κB inhibitor IMD-0354 were purchased from Sigma-Aldrich (St. Louis, MO). Alexa 488 (green)– and Alexa 594 (red)–conjugated anti–mouse and anti–rabbit immunoglobulin G (IgG) antibodies were purchased from Molecular Probes (Eugene, OR). Horseradish peroxidase–conjugated polyclonal goat anti–rabbit IgGs were purchased from Dako (Glostrup, Denmark). The enhanced chemiluminescence Western blotting system was obtained from GE Healthcare UK (Buckinghamshire, UK).
Cell culture and treatments
The cultured HNECs were derived from mucosal tissues of patients with hypertrophic rhinitis or chronic sinusitis who underwent inferior turbinectomy at Sapporo Medical University, the Sapporo Hospital of Hokkaido Railway Company, or the KKR Sapporo Medical Center Tonan Hospital. Informed consent was obtained from all patients, and this study was approved by the ethics committees of the above institutions.The methods for primary culture of HNECs were as reported previously (Koizumi ). Some primary cultured HNECs were transfected with the catalytic component of telomerase, the human catalytic subunit of the hTERT gene, as described previously (Kurose ; Kamekura ; Ohukuni , Ogasawara ). The cells were plated on 35-mm or 60-mm culture dishes (Corning Glass Works, Corning, NY), which were coated with rat tail collagen (500 μg of dried tendon/ml 0.1% acetic acid). The cells were cultured in serum-free bronchial epithelial cell basal medium (Lonza Walkersville, Walkersville, MD) supplemented with bovine pituitary extract (1% vol/vol), 5 μg/ml insulin, 0.5 μg/ml hydrocortisone, 50 μg/ml gentamicin, 50 μg/ml amphotericin B, 0.1 ng/ml retinoic acid, 10 μg/ml transferrin, 6.5 μg/ml triiodothyronine, 0.5 μg/ml epinephrine, 0.5 ng/ml epidermal growth factor (Lonza Walkersville), 100 U/ml penicillin, and 100 μg/ml streptomycin (Sigma-Aldrich) and were incubated in a humidified, 5% CO2/95% air incubator at 37°C. In this experiment, second and third passaged cells were used.Human RSV was grown in the human laryngeal carcinoma cell line HEp-2. For infection, HNECs at 80% confluence were adsorbed at an RSV MOI of 1 for 60 min at 37°C. After adsorption, the viral solutions were removed and the cells were rinsed twice with growth medium and incubated. The virus titers in the supernatant were determined by a plaque-forming assay with HEp-2 cells. Expression of RSV mRNA was confirmed by RT–PCR.Some cells were treated with 0.1–10 μg/ml TGF-β1 or incubated in a 2% CO2/2% O2 incubator balanced by nitrogen. They were pretreated with 10 μM PD98059, 10 μM SB203580, 10 μM LY294002, 10 μM GF109203X, 10 μM SP600125, 0.1 μM IMD-0354, 5 μM PKCα inhibitor, 10 μM PKCε inhibitor, 5 μM PKCθ inhibitor, 5 μM PKCδ inhibitor, and iTGF-βR at 30 min before RSV infection or treatment with 10 ng/ml TGF-β1.
siRNA experiment
For knockdown of human HIF-1α, humanclaudin-4, and humanoccludin, Stealth Select RNAi against the genes was synthesized by Invitrogen (Carlsbad, CA). The sequences for the sense and antisense strands are shown in Table 3. The hTERT-transfected HNECs at 24 h after plating were transfected with 100 nM siRNA using Lipofectamine RNAiMAX Reagent (Invitrogen). At 48 h after transfection, the cells were infected with RSV for 24 h.
TABLE 3:
siRNAs.
siRNA
Sense sequence
Antisense sequence
Claudin-4–siRNA1
5′-GCAACAUUGUCACCUCGCAGACCAU-3′
5′-AUGGUCUGCGAGGUGACAAUGUUGC-3′
Claudin-4–siRNA2
5′-UCCUGUUGGCCGGCCUUAUGGUGAU-3′
5′-AUCACCAUAAGGCCGGCCAACAGGA-3′
Occludin–siRNA1
5′-UGGAUGACUUCAGGCAGCCUCGUUA-3′
5′-UAACGAGGCUGCCUGAAGUCAUCCA-3′
Occludin-siRNA2
5′-GGCCUCUUGAAAGUCCACCUCCUUA-3′
5′-UAAGGAGGUGGACUUUCAAGAGGCC-3′
siRNAs.
RNA isolation, RT–PCR, and real-time PCR analysis
Total RNA was extracted and purified using TRIzol (Invitrogen). One microgram of total RNA was reverse-transcribed into cDNA using a mixture of oligo(dT) and Superscript II reverse transcriptase, according to the manufacturer's recommendations (Invitrogen). Synthesis of each cDNA was performed in a total volume of 20 μl for 50 min at 42°C and terminated by incubation for 15 min at 70°C. PCR was performed in a 20 μl total mixture containing 100 pM primer pairs, 1.0 μl of the 20-μl total RT product, PCR buffer, deoxyribonucleotides, and Taq DNA polymerase, according to the manufacturer's recommendations (Takara, Kyoto, Japan). Amplifications were for 25–35 cycles, depending on the PCR primer pair, with cycle times of 15 s at 96°C, 30 s at 55°C, and 60 s at 72°C. Final elongation time was 7 min at 72°C. Seven microliters of the total 20 μl of PCR product was analyzed by 1% agarose gel electrophoresis with ethidium bromide staining and was standardized using a GeneRuler TM 100BP DNA ladder (Fermentas, Ontario, Canada). To provide a quantitative control for reaction efficiency, PCRs were performed with primers coding for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH). Primers used to detect G3PDH and claudin-4, occludin, RSV G protein, TGF-β1, and HIF-1α are indicated in Table 4.
TABLE 4:
Primers of RT–PCR.
Gene
Forward primer
Reverse primer
Product size (base pairs)
Claudin-4
AGCCTTCCAGGTCCTCAACT
AGCAGCGAGTCGTACACCTT
249
Occludin
TCAGGGAATATCCACCTATCACTTCAG
CATCAGCAGCAGCCATGTACTCTTCAC
189
RSV/G protein
GGGGCAAATGCAAACATGT
GGTATTCTTTTGCATATAGC
621
HIF-1α
CAGAAGATACAAGTAGCCTC
CTGCTGGAATACTGTAACTG
673
TGF-β1
CAGCAACAATTCCTGGCGATA
AAGGCGAAAGCCCTCAATTT
135
G3PDH
ACCACAGTCCATGCCATCAC
TCCACCACCCTGTTGCTGTA
452
Primers of RT–PCR.Real-time PCR detection was performed using a TaqMan Gene Expression Assay kit with a StepOnePlus real-time PCR system (Applied Biosystems, Foster City, CA). The amount of 18S rRNA (Hs99999901) mRNA in each sample was used to standardize the quantities of the following mRNAs: claudin-4 (Hs00533616), occludin (Hs00170162), TGF-β1 (Hs00998133), and HIF-1α (Hs00936366). The relative mRNA expression levels between the control and treated samples were calculated by the difference of the threshold cycle (comparative CT [ΔΔCT] method) and presented as the average of triplicate experiments with a 95% confidence interval.
ELISA
The concentrations of humanIL-8 and TNF-α in cell culture supernatants of hTERT-transfected HNECs at 24–72 h after treatment with RSV were measured using ELISA kits for humanIL-8 and TNF-α (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions.
Western blot analysis
The hTERT-transfected HNECs were scraped from a 60-mm dish containing 300 μl of buffer (1 mM NaHCO3 and 2 mM phenylmethylsulfonyl fluoride), collected in microcentrifuge tubes, and then sonicated for 10 s. The protein concentrations of the samples were determined using a bicinchoninic acid protein assay reagent kit (Pierce Chemical Co., Rockford, IL). Aliquots of 15 μl of protein per lane for each sample were separated by electrophoresis in 4–20% SDSpolyacrylamide gels (Daiichi Pure Chemicals, Tokyo, Japan) and electrophoretically transferred to a nitrocellulose membrane (Immobilon; Millipore, Bedford, UK). The membrane was saturated for 30 min at room temperature with blocking buffer (25 mM Tris, pH 8.0, 125 mM NaCl, 0.1% Tween 20, and 4% skim milk) and incubated with anti–phospho-pan-PKC, anti–pan-PKC, anti–phospho-PKCδ, anti-PKCδ, anti–phospho-NFκB, anti-NFκB, anti–JAM-A, anti-actin, anti-occludin, anti-claudin-1, -4, -7, anti–E-cadherin, anti–HIF-1-α, and anti–RSV/G protein antibodies (Table 2) at room temperature for 1 h. Then it was incubated with horseradish peroxidase–conjugated anti–mouse and anti–rabbit IgG antibodies at room temperature for 1 h. The immunoreactive bands were detected using an enhanced chemiluminescence Western blotting system.
Immunocytochemistry
hTERT-transfected HNECs grown in 35-mm glass-coated wells (Iwaki, Chiba, Japan), were fixed with cold acetone and ethanol (1:1 vol:vol) at –20°C for 10 min. After rinsing in phosphate-buffered saline (PBS), the cells were incubated with anti–RSV/G and /F proteins, and anti-occludin, anti–claudin-4, anti–ZO-1, anti–JAM-A, anti–E-cadherin antibodies (Table 2) overnight at 4°C. Alexa Fluor 488 (green)-conjugated anti–rabbit IgG and Alexa Fluor 592 (red)-conjugated anti–mouse IgG (Invitrogen) were used as secondary antibodies. The specimens were examined and photographed with an Olympus IX 71 inverted microscope (Olympus, Tokyo, Japan) and a confocal laser scanning microscope (LSM510; Carl Zeiss, Jena, Germany).
SEM
Cells grown on coated coverslips were fixed with 2.5% glutaraldehyde/0.1 M PBS (pH 7.3) overnight at 4°C. After several rinses with PBS, the cells were postfixed in 1% osmium tetroxide at 4°C for 3 h and then rinsed with distilled water, dehydrated in a graded ethanol series, and freeze-dried. The specimens were sputter-coated with platinum and observed with a scanning electron microscope (S-4300; Hitachi, Tokyo, Japan) operating at 10 kV.
TEM
The cells were fixed in 2.5% glutaraldehyde/0.1 M PBS (pH 7.3) overnight at 4°C, postfixed in 2% osmium tetroxide in the same buffer, dehydrated in a graded ethanol series, and embedded in Epon 812. Ultrathin sections were then cut on a Sorvall Ultramicrotome MT-5000. The sections were stained with uranyl acetate followed by lead citrate and examined at 60 kV with a JEM transmission electron microscope (JEOL, Tokyo, Japan).
Freeze-fracture analysis
For the freeze-fracture technique, the cells grown on 60-mm dishes were centrifuged into pellets and then immersed in 40% glycerin solution after fixation in 2.5% glutaraldehyde/0.1 M PBS. The specimens were fractured at –150°C to –160°C in a JFD-7000 freeze-fracture device (JEOL) and replicated by deposition of platinum/carbon from an electron beam gun positioned at a 45° angle followed by carbon applied from overhead. Replicas were examined at 100 kV with a JEM transmission electron microscope (JEOL). After the replicas were thawed, they were floated on filtered 10% sodium hypochlorite solution for 30 min in Teflon dishes. They were then washed in distilled water for 30 min, mounted on copper grids, and examined at an acceleration voltage of 100 kV with a JEOL-1200EX transmission electron microscope (JEOL). Morphometric analysis was performed on six freeze-fracture replica images of each one, which were printed at a final magnification of 20,000×. The mean number of tight junction strands was determined by doing numerous counts along a line drawn perpendicular to the junctional axis at 200-nm intervals (Stevenson ).
Measurement of TER
hTERT-transfected HNECs were cultured to confluence on inner chambers of 12-mm Transwell inserts with 0.4-μm-pore-size filters (Corning Life Sciences). TER was measured using an EVOM voltameter with an ENDOHM-12 (World Precision Instruments, Sarasota, FL) on a heating plate (Fine, Tokyo, Japan) adjusted to 37°C. The values were expressed in standard units of ohms per square centimeter and presented as the mean ± SD. For calculation, the resistance of blank filters was subtracted from that of filters covered with cells.
GeneChip analysis
Microarray slides were scanned using a 3D-Gene human 25k. (TORAY, Tokyo, Japan), and microarray images were automatically analyzed using AROS, version 4.0 (Operon Biotechnologies, Tokyo, Japan).
MTT assay
The cells plated on 24-well tissue culture plates (BD Labware, Franklin Lakes, NJ) were treated with 0.1–2 μg/ml C. perfringens enterotoxin for 1 h. The cell survival was evaluated with the colorimetric assay using an MTT Cell Growth Assay Kit (Millipore, Billerica, MA), according to the manufacturer's recommendations.
Data analysis
Signals were quantified using Scion Image Beta 4.02 Win (Scion, Frederick, MD). Each set of results shown is representative of at least three separate experiments. Results are given as means ± SEM. Differences between groups were tested by analysis of variance followed by a post hoc test and an unpaired two-tailed Student's t test and considered to be significant when p < 0.05.
Authors: C J Cohen; J T Shieh; R J Pickles; T Okegawa; J T Hsieh; J M Bergelson Journal: Proc Natl Acad Sci U S A Date: 2001-12-04 Impact factor: 11.205
Authors: Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis Journal: Proc Natl Acad Sci U S A Date: 2013-05-06 Impact factor: 11.205
Authors: Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-11-29 Impact factor: 5.464
Authors: Arij Faksh; Rodney D Britt; Elizabeth R Vogel; Michael A Thompson; Hitesh C Pandya; Richard J Martin; Christina M Pabelick; Y S Prakash Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-11-20 Impact factor: 5.464
Authors: J I Kast; A J McFarlane; A Głobińska; M Sokolowska; P Wawrzyniak; M Sanak; J Schwarze; C A Akdis; K Wanke Journal: Clin Exp Immunol Date: 2017-10-05 Impact factor: 4.330